https://orcid.org/0000-0003-0827-3153
About the Authors
- Vibha Sharma
-
Roles Supervision, Writing – original draft, Writing – review & editing
Affiliation Lydia Becker Institute of Immunology and Inflammation University of Manchester and Royal Manchester Children’s Hospital NHS Foundation Trust, Manchester, United Kingdom
- Jennifer Jobrack
-
Roles Supervision, Writing – original draft, Writing – review & editing
Affiliation Food Allergy Pros LLC, Chicago, IL, United States of America
- Wendy Cerenzia
-
Roles Conceptualization, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliation CE Outcomes, Birmingham, AL, United States of America
- Stephen Tilles
-
Roles Conceptualization, Writing – original draft, Writing – review & editing
Affiliations Medical Affairs, Aimmune Therapeutics, Brisbane, CA, United States of America, University of Washington, Seattle, WA, United States of America
- Robert Ryan
-
Roles Resources, Supervision, Writing – original draft, Writing – review & editing
Affiliation Aimmune Therapeutics, London, United Kingdom
- Regina Sih-Meynier
-
Roles Conceptualization, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
Affiliation Medical Affairs, Aimmune Therapeutics, Brisbane, CA, United States of America
- Stefan Zeitler
-
Roles Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: szeitler@aimmune.com
Affiliation Aimmune Therapeutics Germany GmbH, Munich, Germany
- Michael Manning
-
Roles Supervision, Writing – original draft, Writing – review & editing
Affiliation Medical Research of Arizona, Scottsdale, AZ, United States of America
Competing Interests
The authors have read the journal’s policy and have the following competing interests: SZ, RR, ST and RSM are or were employed by Aimmune Therapeutics Inc. during the course of the study. WC is an employee of CE Outcomes LLC, and JJ is an employee of Food Allergy Pros LLC. VS received speakers’ honoraria from Aimmune and is a principal investigator for Aimmune-sponsored ARC008 and ARC005 studies. VS held consultancy briefly with Novartis and Mead-Johnson and received sponsorship to attend and talk at educational events from other pharmaceutical companies. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.